US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 29, 2021 (5 years ago)

Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications

What was recalled

Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b) 2-count blister pack (NDC 70518-2749-03), Rx only, MFG: Ascend Labs, LLC, Montvale, NJ 07645

Recalling firm
RemedyRepack Inc.
NDC code
70518-2749-02
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0360-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Cefixime recalls

See all